Use of incretin agents and risk of acute and chronic pancreatitis: A population ‐based cohort study
ConclusionsIncretin use was associated with an increased risk of any pancreatitis. Moreover, risk of any and acute pancreatitis was higher when applying a new‐user design. We were not able to detect an association with chronic pancreatitis, but the number in this subgroup was small.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Lotte M. Knapen, Roy G. P. J. de Jong, Johanna H. M. Driessen, Yolande C. Keulemans, Nielka P. van Erp, Marie L. De Bruin, Hubert G. M. Leufkens, Sander Croes, Frank de Vries Tags: ORIGINAL ARTICLE Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Incretin Therapy | Insulin | Obesity | Pancreatitis | Study